A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs

BMJ

Volumn 321, Issue 7256, 2000, Pages 276-281

  Avery, Anthony J ^a   Rodgers, Sarah ^a   Heron, Tara ^a   Crombie, Robert ^b   Whynes, David ^c   Pringle, Mike ^a   Baines, Darrin ^d   Petchey, Roland ^e   Cole, T J ^f  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Enigma Medical Systems   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e CITY UNIVERSITY   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COST CONTROL; DRUG COST; ECONOMIC EVALUATION; GENERAL PRACTICE; HORMONE SUBSTITUTION; HUMAN; PRESCRIPTION; PRIORITY JOURNAL;

DRUG COSTS; DRUG UTILIZATION; ENGLAND; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE MANAGEMENT, MEDICAL;

EID: 0034729946     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.321.7256.276     Document Type: Article

References (17)

1. Audit Commission. A prescription for improvement: towards rational prescribing in general practice. London: HMSO, 1994.
2. Bradlow J, Coulter A. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. BMJ 1993; 307: 1186–1189.
3. Dowell JS, Snadden D, Dunbar JA. Changing to generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995; 310: 505–508.
4. Maxwell M, Heaney D, Howie JGR, Noble S. General practice fundholding: some observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993; 307: 1190–1194.
5. Wilson RPH, Buchan I, Walley T. Alterations in prescribing by general practitioner fundholders: an observational study. BMJ 1995; 311: 1347–1350.
6. Stewart-Brown S, Surender R, Bradlow J, Coulter A, Doll H. The effects of fundholding in general practice on prescribing habits three years after the introduction of the scheme. BMJ 1995; 311: 1543–1547.
7. Baines DL, Tolley KH, Whynes DK. Prescribing, budgets and fundholding in general practice. London: Office of Health Economics, 1997.
8. Baines DL, Whynes DK, Tolley KH. General practitioner fundholding and prescribing expenditure control: evidence from a rural English health authority. Pharmacoeconomics 1997; 11: 350–358.
9. Department of Health. General medical statistics: England and Wales. Leeds: NHS Executive, 1994.
10. Avery AJ. Analysis of PACT data using Optimise software. Prescriber 1999; 10: 109–113.
11. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, 1996. (No 31.)
12. Roberts SJ, Harris CM. Age, sex and temporary resident originated pre-scribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England. BMJ 1993; 307: 485–488.
13. Baines DL, Tolley KH, Whynes DK. The costs of prescribing in dispensing practices. J Clin Pharm Ther 1996; 21: 343–348.
14. Harris CM, Scrivener G. Fundholders' prescribing costs: the first five years. BMJ 1996; 313: 1531–1534.
15. Morton-Jones TJ, Pringle MA. Prescribing costs in dispensing practices. BMJ 1993; 306: 1244–1246.
16. Sibbald B, Wilkie P, Raftery J, Anderson S, Freeling P. Prescribing at the hospital-general practice interface. II: Impact of hospital outpatient dispensing policies in England on general practitioners and hospital consultants. BMJ 1992; 304: 31–34.
17. Rice N, Dixon P, Lloyd D, Roberts D. Derivation of a needs based capitation formula for allocating prescribing budgets. York: Centre for Health Economics, 1999.